Taiwan Bio Therapeutics Co., Ltd Stock

Equities

6892

TW0006892003

Biotechnology & Medical Research

End-of-day quote Taipei Exchange 06:00:00 2024-07-04 pm EDT 5-day change 1st Jan Change
52.6 TWD -4.54% Intraday chart for Taiwan Bio Therapeutics Co., Ltd +28.14% +53.35%
Dynamic Chart
1 day-4.54%
1 week+28.14%
Current month+28.14%
1 month+37.70%
3 months+48.38%
6 months+55.39%
Current year+53.35%
More quotes
1 week
40.85
Extreme 40.85
60.10
1 month
37.50
Extreme 37.5
60.10
Current year
32.60
Extreme 32.6
60.10
1 year
31.10
Extreme 31.1
60.10
3 years
26.35
Extreme 26.35
60.10
5 years
26.35
Extreme 26.35
60.10
10 years
26.35
Extreme 26.35
60.10
More quotes
Managers TitleAgeSince
Chief Executive Officer - 18-06-14
Director of Finance/CFO - 21-11-30
Chief Operating Officer - 18-10-31
Members of the board TitleAgeSince
Director/Board Member 71 21-06-23
Director/Board Member - 15-06-15
Chairman - 17-06-15
More insiders
Date Price Change Volume
24-07-05 52.6 -4.54% 1,087,248
24-07-04 55.1 +9.33% 2,584,169
24-07-03 50.4 +15.60% 1,877,330
24-07-02 43.6 +4.18% 649,675
24-07-01 41.85 +1.95% 309,135

End-of-day quote Taipei Exchange, July 04, 2024

More quotes
Taiwan Bio Therapeutics Co Ltd is a Taiwan-based company mainly engaged in the development of new allogeneic stem cell drugs and the provision of contract development and manufacturing organization (CDMO) services. The main products include Chondrochymal for the treatment of degenerative arthritis of the knee, Biochymal for the treatment of difficult non-healing wounds caused by lower extremity ischemia, OmniMSC/TBPCB201 for the treatment of acute myocardial infarction, and MSC-VEGF for the treatment of lower extremity ischemia. The cell processing center (CPC) is engaged in the provision of a full set of CDMO services, process scale-up services, inspection and development services, and quality control commissioned inspection services. The Company mainly operates in Taiwan market.
More about the company